- Earnings Per Share (EPS) is estimated to be $0.93, reflecting a 9.4% increase from the previous year.
- Projected revenue of approximately $995.1 million, marking a 5.6% rise compared to the same quarter last year.
- Financial ratios such as the price-to-earnings (P/E) ratio of approximately 38.95 and a debt-to-equity ratio of about 0.31 highlight the company’s market valuation and financial health.
The Cooper Companies, Inc. (NASDAQ:COO) is a global medical device company that operates through two main segments: CooperVision and CooperSurgical. CooperVision focuses on contact lenses, while CooperSurgical provides products and services for women’s health care. The company is set to release its fiscal second-quarter results for 2025 on May 9, following the closing bell.
Wall Street analysts estimate COO’s earnings per share (EPS) to be $0.93, reflecting a 9.4% increase from the previous year. This stability in earnings estimates over the past month suggests that analysts have not revised their initial projections. Such stability is crucial as empirical research highlights a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
The company’s revenue is projected to be approximately $995.1 million, marking a 5.6% rise compared to the same quarter last year. This growth is consistent with the Zacks Consensus Estimate, which projects revenues of $982 million, a 5.4% increase from the same quarter last year. Cooper Companies’ revenue growth is driven by strong performance in both its CooperVision and CooperSurgical segments.
In the last quarter, COO’s earnings matched the Zacks Consensus Estimate, and the company has exceeded earnings expectations in three of the last four quarters, achieving an average surprise of 2.98%. This track record of meeting or exceeding expectations may influence investor confidence and stock performance.
COO’s financial metrics provide insight into its market valuation. The company has a price-to-earnings (P/E) ratio of approximately 38.95, indicating the market’s valuation of its earnings. The price-to-sales ratio stands at about 4.09, while the enterprise value to sales ratio is around 4.71. These ratios reflect the company’s market value relative to its sales and revenue. Additionally, COO’s debt-to-equity ratio is approximately 0.31, indicating a moderate level of debt relative to equity, and a current ratio of about 1.99, suggesting the company’s ability to cover its short-term liabilities with its short-term assets.
